Recent news coverage does not pertain directly to Valuence Merger Corp. I but covers broader market topics and other companies' earnings and developments.

• Alphabet is facing thousands of lawsuits, with historical context on potential outcomes [N1].
• Medicare launched a new program that could lead to savings for seniors [N2].
• CMCT and CSP Inc. released earnings call transcripts for Q2 and Q3 2026 respectively [N3][N4].
• Guidance on social security benefits and Medicare open enrollment timing is available [N5][N6].
• Home Depot and Lowe's have raised dividends for 17 consecutive years [N7].
• Stocks closed lower amid worries about the US economy [N8].

The company’s structure as a SPAC provides capital and a vehicle to pursue a business combination in targeted sectors. The multiple extensions to the combination deadline and continued sponsor support via convertible notes indicate ongoing efforts to complete a transaction. If a suitable target is identified and combined, the company could transition to an operating entity in a high-growth sector.

The company has not completed a business combination within the original or extended deadlines, resulting in Nasdaq delisting and trading suspension. The very low liquidity ratios and net losses reflect financial strain. Failure to complete a business combination by the final deadline could lead to liquidation and loss of invested capital. The lack of operational history and ongoing redemptions reduce visibility into future prospects.

As a blank check company, Valuence Merger Corp. I does not have an operating business or competitive moat. Its value depends on successfully identifying and completing a business combination with a target company. The company’s focus on Asian targets in life sciences and sustainable technology may provide a thematic investment focus, but no operational advantages or proprietary assets are currently held.

• Business Combination Risk: The company has not completed a business combination and faces the risk of failing to identify or consummate a suitable transaction within the extended deadlines.
• Liquidity Risk: As of June 30, 2026, the company has a very low current ratio (0.01) and cash ratio (0), indicating limited liquidity to meet current liabilities.
• Regulatory and Listing Risk: The company’s securities were delisted from Nasdaq due to failure to complete a business combination within the required timeframe, leading to trading suspension and transfer to OTC Pink.
• Sponsor Dependency: The company relies on the sponsor and affiliates for extension contributions and working capital through convertible promissory notes, which may be subject to forfeiture if no business combination occurs.

• Valuence Merger Corp. I is a blank check company incorporated in the Cayman Islands on August 27, 2021, formed to effect a business combination with one or more businesses or entities.
• The company focuses on identifying a target based in Asia (excluding China, Hong Kong, and Macau) developing breakthrough life sciences technology and/or sustainable technology platforms.
• The company has not commenced operations and generates no operating revenues; income is from interest on IPO proceeds.
• The IPO was consummated on March 3, 2022, raising gross proceeds of $200 million from 20 million units at $10 each, plus additional proceeds from private placement warrants and over-allotment options, totaling approximately $226.7 million held in a trust account.
• The trust account funds were initially invested in U.S. government securities or money market funds but were moved to an interest-bearing bank deposit account as of March 1, 2024.
• The company has extended its deadline to complete a business combination multiple times, with the current combination period extended to March 3, 2026, and provisions to extend further up to March 3, 2027, subject to sponsor deposits.
• The company has issued convertible promissory notes to the sponsor and affiliates to fund extension contributions and working capital, repayable upon business combination or liquidation.
• As of June 30, 2026, the company had cash and equivalents of $25,017 and current assets of $56,150, but current liabilities of $5,174,327, resulting in a very low current ratio of 0.01 and a cash ratio of 0.
• The company reported a net loss of $73,687 for the period ending June 30, 2026.
• The company’s shares are subject to redemption rights upon completion of a business combination, with redemption price based on trust account funds.
• The company’s warrants were transferred from Nasdaq Global Market to Nasdaq Capital Market in June 2024 due to compliance issues.
• Trading of the company’s securities was suspended on Nasdaq in March 2025 due to failure to complete a business combination within 36 months of IPO and moved to OTC Pink.
• Recent news items in the public domain are unrelated to the company’s business or operations and focus on general market and other companies’ topics.